financetom
Business
financetom
/
Business
/
Pagaya Technologies Prices Upsized $140 Million Debt Offering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pagaya Technologies Prices Upsized $140 Million Debt Offering
Sep 28, 2024 10:54 PM

04:14 AM EDT, 09/27/2024 (MT Newswires) -- Pagaya Technologies ( PGY ) said late Thursday it priced a private offering of $140 million of 6.125% exchangeable senior notes due 2029, upsized from a previous $125 million.

The offering is scheduled to settle on Oct. 1.

The company granted the initial purchasers an option to purchase up to $20 million of additional notes.

Pagaya ( PGY ) said it plans to use net proceeds to pay down debt and for general corporate purposes.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Jun 3, 2024
June 3 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 0930 GMT on Monday: ** Thai entertainment platform GMM Music said Tencent ( TCTZF ) and Tencent Music Entertainment ( TME ) will acquire a 10% stake in the company for $70 million, solidifying its spin-off plan. ** Blackstone raised its offer for Hipgnosis Songs Fund...
Summit Therapeutics Generates $200 Million Through Share Sale; Expand License Territories for Ivonescimab
Summit Therapeutics Generates $200 Million Through Share Sale; Expand License Territories for Ivonescimab
Jun 3, 2024
06:00 AM EDT, 06/03/2024 (MT Newswires) -- Summit Therapeutics ( SMMT ) said Monday it received and accepted an unsolicited offer from an institutional investor to buy about 22.2 million shares of the company's common stock at $9 per share for gross proceeds of about $200 million. The company said it plans to use the net proceeds to progress the...
Intellia Therapeutics' NTLA-2002 Phase 1 Study Observes 98% Mean Reduction in Monthly Attack Rate
Intellia Therapeutics' NTLA-2002 Phase 1 Study Observes 98% Mean Reduction in Monthly Attack Rate
Jun 3, 2024
05:22 AM EDT, 06/03/2024 (MT Newswires) -- Intellia Therapeutics ( NTLA ) said Sunday that it observed a 98% mean reduction in monthly attack rate in the phase 1 portion of its ongoing phase 1/2 study of NTLA-2002. The study is evaluating the safety and activity of NTLA-2002 in adults with Type I or Type II hereditary angioedema, or HAE,...
UK's Monzo reports first annual profit, targets European expansion
UK's Monzo reports first annual profit, targets European expansion
Jun 3, 2024
* Monzo posts first annual profit since 2015 launch * 'Heartening' to see IPO activity, but no update on plans - CEO * FCA probe continues but no longer assessing criminal liability (Adds CEO comments, further details and context throughout) By Iain Withers LONDON, June 3 (Reuters) - Monzo reported its first annual profit on Monday in a milestone for...
Copyright 2023-2026 - www.financetom.com All Rights Reserved